Centaurus Financial, Inc. Fulgent Genetics, Inc. Transaction History

Centaurus Financial, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$49.85 - $96.11 $65,403 - $126,096	-1,312 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$77.3 - $105.0 $89,049 - $120,960	-1,152 Reduced 46.75%	1,312 $132,000
Q3 2021 Nov 12, 2021	BUY	$74.87 - $110.87 $184,479 - $273,183	2,464 New	2,464 $222,000
Q2 2021 Aug 10, 2021	SELL	$66.8 - $100.45 $71,609 - $107,682	-1,072 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$59.3 - $183.85 $63,569 - $197,087	1,072 New	1,072 $104,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.